MaxoCore Pharmaceuticals Inc develops novel small molecule drugs to meet the challenges of modern lifestyle associated metabolic diseases e.g. type 2 Diabetes, hypercholesterolaemia and obesity. More
Displaying 11..11 of 11 -
per page
Previous page
Order by